Continuing Professional
Education

The University of Maryland School of Social Work Office of Continuing Professional Education is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs and maintains full responsibility for this program. We are also approved to offer CE to Licensed Counselors and Psychologists. Clinicians in other states should verify with their licensing Board. For any questions, comments or concerns, please email cpe@ssw.umaryland.edu

On Demand

Also Available

Multiday Session Course

On Demand

Also Available

Multiday Session Course

On Demand

Part 7: Clozapine and Hematologic Monitoring: Focus on Neutropenia and Use of Point of Care Monitoring Device

Total Credits: 2.25 including 2.25 Category II CEs

Instructors:: Gopal Vyas, DO | Fred Nucifora, D.O., M.H.S., Ph.D.,
Duration:: 2 Hours 25 Minutes
Format:: Audio and Video

Price
$0.00 - Late Fee

Description

This video provides approximately 15-minute didactic overview of clozapine and hematologic monitoring with a focus on neutropenia and use of a point of care monitoring device with a focus on making sure the participants learn how to list types of hematologic side effects that can occur with clozapine, describe the FDA recommended criteria for absolute neutrophil count (ANC) monitoring for clozapine use, and compare and contrast point of care monitoring and venous blood draws for clozapine. This is followed by a discussion on the topic between the presenter, other experts and providers.

Session 20: Talking to Patients and Families about Clozapine/Motivational Techniques (70 minutes)

This video provides approximately 15-minute didactic overview about talking to patients and families about clozapine/ motivational techniques with a focus on making sure the participants learn how to describe strategies to introduce clozapine as a treatment option to patients and families, list elements of clozapine treatment that are important to include in the patient and family discussions, and delete barriers to care to help patients and families have an optimal clozapine experience. This is followed by a discussion on the topic between the presenter, other experts and providers.

Session 21: Clozapine Response – Don’t Miss it: What to do if Patient gets “Worse on Clozapine”, Adequacy of Clozapine trial and Discontinuation of Clozapine When Needed (75 minutes)